Table 8 Use of NSAIDs and/or corticosteroids in follow-up
Anti-TNF | DMARDs | Non- users | |
|---|---|---|---|
2002–2006 | |||
Total number of patients | 557 | 1144 | 656 |
NSAIDs in follow-up | 372 (66.8) | 788 (68.9) | 451 (68.8) |
Corticosteroid in follow-up | 344 (61.8) | 650 (56.8) | 353 (53.8) |
NSAIDs and/or corticosteroid in follow-up | 460 (82.6) | 959 (84.7) | 531 (80.9) |
2007–2012 | |||
Total number of patients | 690 | 1651 | 532 |
NSAIDs in follow-up | 389 (56.4) | 981 (59.4) | 257 (48.3) |
Corticosteroid in follow-up | 413 (59.9) | 790 (47.8) | 276 (51.9) |
NSAIDs and/or corticosteroid in follow-up | 568 (82.3) | 1251 (75.8) | 396 (74.4) |